Triple
T5689006
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | FDA traditional approval |
E125382
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | drug regulatory approval pathway |
C3993
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: drug regulatory approval pathway Context triple: [FDA traditional approval, instanceOf, drug regulatory approval pathway]
-
A.
pharmaceutical drug
A pharmaceutical drug is a chemically defined substance or combination of substances administered to diagnose, treat, prevent, or alleviate disease or medical conditions in humans or animals.
-
B.
regulatory filing
chosen
A regulatory filing is an official document or set of documents submitted to a government or regulatory authority to report required information, demonstrate compliance, or request approval related to an organization’s activities.
-
C.
medical device regulation system
A medical device regulation system is a framework of processes, rules, and oversight mechanisms that govern the evaluation, approval, monitoring, and post-market surveillance of medical devices to ensure their safety, effectiveness, and compliance with regulatory standards.
-
D.
drug development program
A drug development program is a structured, multi-phase process that discovers, tests, and advances a potential therapeutic compound from initial concept through clinical evaluation and regulatory approval for patient use.
-
E.
drug development support program
A drug development support program is a structured set of services, resources, and guidance designed to assist researchers and companies in efficiently advancing drug candidates from discovery through preclinical and clinical development to regulatory approval.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0082bb19c8190823a4facd3cba79b |
completed | March 22, 2026, 3:18 p.m. |
Created at: March 22, 2026, 3:44 p.m.